DelveInsight has launched a new report on Cold Agglutinin Disease Market Insights, Epidemiology and Market Forecast-2030
DelveInsight’s Alopecia Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Alopecia epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Hair loss, also knownas alopecia orbaldness, refers toa loss of hair from part of thehead or body.Typically,atleasttheheadisinvolved,andtheseverityofhairlosscanvaryfromasmall areatotheentirebody. About one-third of women experience hair loss at some time in their lives; among postmenopausal women, as many as two-thirds suffer hair thinning or bald spots. Hairloss in women often has a greater impact than hair loss does on men, because it is less socially acceptableforthem.Alopeciacanseverelyaffectawoman’semotionalwell-beingandquality oflif.
Click Here- Free sample page
Epidemiology
The Alopecia epidemiology division provides insights about historical and current patient pool and forecasted trend for every seven major countries. The Alopecia epidemiology data are studied through all possible division to give a better understanding of the Disease scenario in 7MM. The Alopecia epidemiology segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2017 to 2030. It also helps to recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.
Report key facts-
1. As per the study by Severi et al. titled, “Androgenetic alopecia in men aged 40–69 years: prevalence and risk factors,” the prevalence of vertex and full androgenic alopecia increased with age from approximately 30% (age 40–55 years) to 50% (age65–69years.
2. According to the National Alopecia Areata Foundation,alopeciaareataaffectsasmanyas6.8 million people in the US with a lifetime risk of 2.1%. People of all ages, both sexes and all ethnic groups can develop alopecia are ata.
3. As per the article by Whiting et al. titled, “Cicatricial alopecia: clinicopathological findings and treatment,” the prevalence of cicatricial alopeciaintheUSis7%.
Some of key companies are working on this disease which are given below-
1. Merck Pharma Co.
2. Johnson & Johnson Co.
3. Samumed
Name of drugs covered which are given below-
1. Propecia (finasteride)
2. Rogaine (Minoxidil)
3. SM04554
1. Key Insights
2. Executive Summary of Alopecia
3. Competitive Intelligence Analysis for Alopecia
4. Alopecia: Market Overview at a Glance
4.1. Alopecia Total Market Share (%) Distribution in 2017
4.2. Alopecia Total Market Share (%) Distribution in 2030
5. Alopecia: Disease Background and Overview
5.1. Introduction
5.2. Sign and Symptoms
5.3. Pathophysiology
5.4. Risk Factors
5.5. Diagnosis
6. Patient Journey
7. Alopecia Epidemiology and Patient Population
7.1. Epidemiology Key Findings
7.2. Assumptions and Rationale: 7MM
7.3. Epidemiology Scenario: 7MM
7.3.1. Alopecia Epidemiology Scenario in the 7MM (2017-2030)
7.4. United States Epidemiology
7.4.1. Alopecia Epidemiology Scenario in the United States (2017-2030)
7.5. EU-5 Country-wise Epidemiology
7.5.1. Germany Epidemiology
7.5.1.1. Alopecia Epidemiology Scenario in Germany (2017-2030)
7.5.2. France Epidemiology
7.5.2.1. Alopecia Epidemiology Scenario in France (2017-2030)
7.5.3. Italy Epidemiology
7.5.3.1. Alopecia Epidemiology Scenario in Italy (2017-2030)
7.5.4. Spain Epidemiology
7.5.4.1. Alopecia Epidemiology Scenario in Spain (2017-2030)
7.5.5. United Kingdom Epidemiology
7.5.5.1. Alopecia Epidemiology Scenario in the United Kingdom (2017-2030)
7.5.6. Japan Epidemiology
7.5.6.1. Alopecia Epidemiology Scenario in Japan (2017-2030)
8. Treatment Algorithm, Current Treatment, and Medical Practices
8.1. Alopecia Treatment and Management
8.2. Alopecia Treatment Algorithm
9. Unmet Needs
10. Key Endpoints of Alopecia Treatment
11. Marketed Products
11.1. List of Marketed Products in the 7MM
11.2. Drug Name: Company Name
11.2.1. Product Description
11.2.2. Regulatory Milestones
11.2.3. Other Developmental Activities
11.2.4. Pivotal Clinical Trials
11.2.5. Summary of Pivotal Clinical Trial
12. Emerging Therapies
12.1. Key Cross
12.2. Drug Name: Company Name
12.2.1. Product Description
12.2.2. Other Developmental Activities
12.2.3. Clinical Development
12.2.4. Safety and Efficacy
12.2.5. Product Profile
13. Alopecia: Seven Major Market Analysis
13.1. Key Findings
13.2. Alopecia Market Size in 7MM
13.3. Alopecia Market Size by Therapies in the 7MM
14. Attribute analysis
15. 7MM: Market Outlook
15.1. United States: Market Size
15.1.1. Alopecia Total Market Size in the United States
15.1.2. Alopecia Market Size by Therapies in the United States
15.2. EU-5 countries: Market Size and Outlook
15.3. Germany Market Size
15.3.1. Alopecia Total Market Size in Germany
15.3.2. Alopecia Market Size by Therapies in Germany
15.4. France Market Size
15.4.1. Alopecia Total Market Size in France
15.4.2. Alopecia Market Size by Therapies in France
15.5. Italy Market Size
15.5.1. Alopecia Total Market Size in Italy
15.5.2. Alopecia Market Size by Therapies in Italy
15.6. Spain Market Size
15.6.1. Alopecia Total Market Size in Spain
15.6.2. Alopecia Market Size by Therapies in Spain
15.7. United Kingdom Market Size
15.7.1. Alopecia Total Market Size in the United Kingdom
15.7.2. Alopecia Market Size by Therapies in the United Kingdom
15.8. Japan Market Outlook
15.8.1. Japan Market Size
15.8.2. Alopecia Total Market Size in Japan
15.8.3. Alopecia Market Size by Therapies in Japan
16. Access and Reimbursement Overview of Alopecia
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
20.1. Bibliography
20.2. Report Methodology
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight
Why should you buy this report?
- The Alopecia Epidemiology report will allow the user to -
- Develop business strategies by understanding the trends shaping and driving the global Alopecia market
- Quantify patient populations in the global Alopecia market to improve product design, pricing, and launch plans
- Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Alopecia therapeutics in each of the markets covered
- Understand the magnitude of Alopecia population by its epidemiology
- The Alopecia Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over 11-year forecast period using reputable sources
Related Reports-
Alopecia - Epidemiology Forecast to 2030
Alopecia - Pipeline Insights, 2020
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email:Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
